Lv5
900 积分 2024-03-13 加入
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
2天前
已完结
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
2天前
已完结
RNA Interference With Zilebesiran for Mild to Moderate Hypertension
2天前
已完结
Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension
2天前
已完结
Pharmacological Management of Primary Arterial Hypertension: A Century of Expert Opinions in Cecil Textbook of Medicine
2天前
求助中
Long-Term Favorable Cardiac Remodeling in Obstructive Hypertrophic Cardiomyopathy Patients Treated With Mavacamten for Up to 128 Weeks
15天前
已完结
Prevalence of Silent Atherosclerosis across Adult Life
19天前
已完结
Eplontersen for Transthyretin Amyloid Cardiomyopathy
20天前
已完结
Incidence of symptomatic tachycardia in untreated patients with paroxysmal supraventricular tachycardia
29天前
已关闭
Unrecognized paroxysmal supraventricular tachycardia. Potential for misdiagnosis as panic disorder
1个月前
已关闭
皖公网安备34019202002308
